Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations
Michael N Oxman1, Kenneth E Schmader2
1Infectious Diseases Section, Medicine Service, Veterans Affairs San Diego Healthcare System Division of Infectious Diseases, University of California San Diego School of Medicine.
Abstract
No abstract available in PubMed .


